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a b s t r a c t
Diabetes is strongly associated with cardiovascular disease, but the mechanisms, structural and biome-
chanical consequences of aberrant blood vessel remodelling remain poorly deﬁned. Using an experimen-
tal (streptozotocin, STZ) rat model of diabetes, we hypothesized that diabetes enhances extracellular
protease activity in the aorta and induces morphological, compositional and localized micromechanical
tissue remodelling. We found that the medial aortic layer underwent signiﬁcant thickening in diabetic
animals but without signiﬁcant changes in collagen or elastin (abundance). Scanning acoustic microscopy
demonstrated that such tissue remodelling was associated with a signiﬁcant decrease in acoustic wave
speed (an indicator of reduced material stiffness) in the inter-lamellar spaces of the vessel wall. This
index of decreased stiffness was also linked to increased extracellular protease activity (assessed by
semi-quantitative in situ gelatin zymography). Such a proteolytically active environment may affect
the macromolecular structure of long-lived extracellular matrix molecules. To test this hypothesis, we
also characterized the effects of diabetes on the ultrastructure of an important elastic ﬁbre component:
the ﬁbrillin microﬁbril. Using size exclusion chromatography and atomic force microscopy, we isolated
and imaged microﬁbrils from both healthy and diabetic aortas. Microﬁbrils derived from diabetic tissues
were fragmented, morphologically disrupted and weakened (as assessed following molecular combing).
These structural and functional abnormalities were not replicated by in vitro glycation. Our data suggest
that proteolysis may be a key driver of localized mechanical change in the inter-lamellar space of diabetic
rat aortas and that structural proteins (such as ﬁbrillin microfbrils) may be biomarkers of diabetes
induced damage.
 2014 Acta Materialia Inc. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).
1. Introduction
Diabetes is one of the most common non-communicable dis-
eases in the world, with an estimated 382 million people affected
worldwide in 2013 [1]. Whether as type 1 or type 2, its major out-
comes, or health-related events leading to illness or death, are car-
diovascular [2], resulting in reduced life expectancy and greatly
increased healthcare costs. In both types, vascular dysfunction
occurs early in the disease process [3–5]. The structural and biome-
chanical alterations in diabetic macro- and micro-vasculature are
complex and the mechanisms remain poorly understood [2,6,7].
A better understanding of the processes driving vascular remodel-
ling in diabetes should help develop new therapies [2].
Impaired biomechanical function of the diabetic aorta is gener-
ally attributed to changes in the extracellular matrix (ECM), nota-
bly in collagen abundance. Most studies suggest that collagen
ﬁbrosis causes increased vessel stiffness in the diabetic aorta
[6,8,9] but there is a lack of consensus in the literature. For
example, not all studies have reported increased collagen content
in diabetes [10,11]. Potential mechanisms which underpin this
ECM remodelling and hence vessel stiffening include matrix
metalloproteinase (MMP) driven catabolic pathways [12,13], the
accumulation of advanced glycation end-product (AGE) cross-links
[6,8] and aberrant transforming growth factor-b (TGF-b) signalling
[14]. This latter mechanism may be initiated by disruption of
ﬁbrillin microﬁbril based TGF-b sequestration, as is evident in the
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profound aortic remodelling which characterizes the vessel prior to
rupture in Marfan syndrome, a congenital disease that compro-
mises the mechanical integrity of connective tissues, particularly
the aorta [15,16].
The contribution that micromechanical mapping can make to
identifying local vessel stiffening within the vessel wall was high-
lighted in an earlier review [17] Using scanning acoustic micros-
copy (SAM), we have previously demonstrated that increased
tissue acoustic wave speed (and hence increased stiffness) was
localized to medial inter-lamellar regions in both ageing sheep
[18] and Cardiotrophin-1 (CT-1) treated rat aortas [19]. In this
study, we have used SAM with conventional histology and semi-
quantitative in situ zymography to test our ﬁrst hypothesis that
experimental type 1 diabetes would induce morphological, compo-
sitional and localized micromechanical remodelling in the aorta
associated with increased protease activity.
The lack of consensus regarding structural changes in the dia-
betic aorta may be due, in part, to the inability of conventional light
microscopy to characterize thechanging compositionand/ormacro-
molecular structure of long-lived ECM proteins [20–22]. Fibrillar
collagens and elastic ﬁbres are complexmacromolecular assemblies
whose function may be impaired, without affecting their global
charge distribution or epitope availability andhence their detection,
byhistological or immunohistochemical techniques. Fibrillinmicro-
ﬁbrils, as key elastic ﬁbre components, play a central role in the
pathogenesis of Marfan syndrome. The longevity and well-charac-
terized structure of these microﬁbrils make them potential struc-
tural biomarkers of aberrant tissue remodelling and their role in
Marfan syndrome suggests that in situ microﬁbril damage may be
a key trigger for further inﬂammatory events [16,23]. In this study
therefore we have also employed atomic force microscopy (AFM)
and molecular combing [24] to test a second hypothesis that acute
diabeteswill compromise the ultrastructure and hence extensibility
of isolated aortic ﬁbrillin microﬁbrils [25,26].
2. Materials and methods
2.1. Animals and tissues
All procedures accorded to the UK Animals (Scientiﬁc Proce-
dures) Act 1986 and the University of Manchester ethical review
process. Type 1 diabetes was induced in adult male Wistar rats
(Charles River, Kent, UK; 250–300 g; n = 9) by a single intraperito-
neal injection of streptozotocin (STZ: Sigma Aldrich, Poole, Dorset,
UK), freshly dissolved in normal saline, at a dose of 55 mg kg–1
[27]. Hyperglycaemia was conﬁrmed (>15 mmol l–1) three days fol-
lowing the STZ injection and at the end of the experiment (see
Table 1). Experimental and control animals were group housed in
Double Decker Rat Housing ICV cages (Tecniplast, Kettering, UK)
for 56 ± 0 and 56 ± 1 day, respectively, after which time they were
killed by anaesthetic overdose (isoﬂurane). The mean start and end
weights for the controls were 313 ± 11 g and 517 ± 23 g, respec-
tively. The mean start and end weights for the diabetics were
314 ± 13 g and 352 ± 18 g, respectively. The mean blood glucose
for the controls was 10.5 ± 0.9 mmol l–1. These values are
expressed as means ± standard error of the mean (SEM).
The descending thoracic aorta was dissected and either snap-
frozen in liquid nitrogen, or prepared for cryosectioning by freez-
ing in optimal cutting temperature (OCT) resin (Sakura Fintek Eur-
ope BV, Alphen aan den Rijn, The Netherlands) in pre-cooled
isopentane and stored at 80 C [18].
2.2. SAM
Localized changes in tissue acoustic wave speed were measured
for hydrated, unﬁxed aortic cryosections (5 lmthickness)with SAM
as previously described using the Multi-Layer Phase Analysis
(MLPA) method [28]. Brieﬂy, SAM imaging was conducted on a KSI
2000 microscope (PVA TePla Analytical Systems GmbH; Herborn,
Germany) modiﬁed with a custom data acquisition and control sys-
tem. Imaging was conducted at 760 MHz in this study, which pro-
vided a spatial resolution of 1.3 lm. The acoustic wave speed (tL)
is related to Young’s modulus (stiffness) by the following equation:
tL ¼
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where q is the mass density (kg m3), and C11 (Pa) is a component
of the elastic stiffness tensor, which can be expressed a function of
Young’s modulus (E) and Poisson’s ratio (m) [29]. Hence, a higher
acoustic wave speed indicates a stiffer material.
The resulting SAM images contain sufﬁcient structural informa-
tion to allow the acoustic wave speed of the elastic lamellae and
inter-lamellar regions of the aortic wall to be measured indepen-
dently (Fig. 1).
2.3. Histological and biochemical analysis
2.3.1. Quantiﬁcation of collagen and elastin content
The relative ﬁbrillar collagen and elastic ﬁbre content (tissue
section area) from control and diabetic rat aortas (n = 6 per group)
was quantiﬁed as previously described [18]. Brieﬂy, 5 lm cryosec-
tions were taken from the same animals used for SAM. Collagen
content was quantiﬁed by obtaining both bright ﬁeld and circular
polarized light images of identical contiguous regions around the
aortic circumference. The blue channel from the bright ﬁeld image
was thresholded (which enabled us to exclude voids in the tissue)
and total tissue area was measured in pixels. The red channel from
the polarized light image of the identical region was thresholded to
reveal the collagen positive pixels. Collagen content of each image
was then expressed as percentage tissue area. For elastin quantiﬁ-
cation, the blue channel from the bright ﬁeld images of Millers
stained sections were thresholded to measure the total tissue area
(and to exclude voids in the tissue). The red channel was then
thresholded to exclusively reveal the blue-black stained elastin
ﬁbres. The total elastin positive pixels were expressed as a percent-
age of total tissue area. Medial thickness (intimal to external elastic
lamina of the medial layer) was determined from complete
circumference montages of bright ﬁeld images (at 100 magniﬁca-
tion) of Millers elastic stained cryosections. The images were then
Table 1
Body weight (start and end weights) and end blood glucose parameters for the Wistar
rats. Note all readings for the diabetic rats were higher than the upper limit of
detection for the glucose meter, i.e. >27.8 mmol l–1.
Group Start weight (g) End weight (g) Blood glucose (mmol l–1)
Control 342 629 7.3
Control 365 598 8.1
Control 331 545 9.7
Control 322 647 6.6
Control 318 610 13.7
Control 261 429 12.4
Control 299 514 11.9
Control 282 517 12.7
Control 301 524 12.5
Diabetic 320 305 >27.8
Diabetic 341 404 >27.8
Diabetic 333 396 >27.8
Diabetic 350 329 >27.8
Diabetic 357 437 >27.8
Diabetic 329 362 >27.8
Diabetic 247 282 >27.8
Diabetic 261 300 >27.8
Diabetic 290 350 >27.8
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thresholded to remove the glass component of the image before
medial thickness measurements were taken, therefore only pixels
which contained tissue were counted. To ensure that all measure-
ments were taken perpendicular to the intima, curved regions of
the aortic wall were straightened using an ImageJ (US National
Institutes of Health, Bethesda, Maryland, USA) implementation of
a cubic-spline interpolation algorithm [30,31].
2.3.2. Characterization of ECM protease activity by in situ gelatin
zymography
The potential inﬂuence of aberrant ECM protease activity on
aortic wall remodelling in diabetes was assessed by in situ gelatin
zymography of tissue cryosections [32–34]. Following incubation
with an agarose stabilized mixture of the ﬂuorogenic substrate
DQ-gelatin and 40,6-diamidino-2-phenylindole (DAPI) for 1 h at
room temperature, areas of gelatin cleavage and DNA localization
were visualized by ﬂuorescence microscopy with ﬂuorescein iso-
thiocyanate (FITC) or DAPI ﬁlters. Relative gelatinase activity was
subsequently quantiﬁed for 100 pixel wide regions between the
intimal layer and external elastic lamina (n = 9; 3 regions from
three cryosections) in control and diabetic rat cryosections (n = 5
per group).
Low gelling temperature agarose (Sigma Aldrich, Poole, Dorset,
UK) was dissolved in 100 ml phosphate-buffered saline (to a ﬁnal
concentration of 10 mg ml–1) in a water bath at 80 C, until a clear
solution was obtained. The agarose was stored at 4 C in air tight
vials. DQ gelatin (Invitrogen) was dissolved to a concentration of
1 mg ml–1 in dH2O and also stored at 4 C.
The agarose was heated to 60 C until it had melted and then
cooled to 45 C. The tissue sections, which were 5 lm thick cryo-
sections, were brought to room temperature for 10 min. DAPI
was added to the melted agarose to a ﬁnal concentration of
1 lg ml–1 and a diluted DQ gelatin stock solution (1:10) was added
to the agarose/DAPI solution; 40 ll of agarose/DAPI/DQ gelatin
solution was added onto each tissue section. A coverslip was then
placed on the samples to ensure uniformity of ﬁlm thickness across
the specimens. The samples were then incubated at 4 C in the dark
for 18 h (overnight).
Following the incubation, the samples were visualized and
imaged immediately. Image analysis was conducted with ImageJ
and three regions were analyzed per section, with the green chan-
nel used for analysis. Following background subtraction, the mean
ﬂuorescence intensity per lm2 was then calculated for nine
regions (n = 3 per section) per animal. Each region measured
20 lm along the axis of the vessel wall and encompassed both
the medial and intimal layers.
2.4. Extraction and ultrastructural characterization of ﬁbrillin
microﬁbrils
Fibrillin microﬁbrils were extracted from diabetic and healthy
rat aortas by bacterial collagenase digestion, puriﬁed by size-exclu-
sion chromatography at physiological pH and adsorbed on
poly-L-lysine coated mica substrates [26,35].
2.4.1. AFM
The ﬁbrillin microﬁbrils were imaged with AFM (Bruker Multi-
mode and Nanoscope IIIa controller: Bruker AXS, Cambridge, UK)
using high aspect ratio etched silicon nitride probes with a nominal
spring constant and resonant frequency of 42 N m1 and 300 kHz,
respectively (OTESPA probes, Bruker AXS, Cambridge, UK), as pre-
viously described [26,36].
2.4.2. AFM image analysis
Microﬁbril morphology was characterized by measuring length
(numberof beadspermicroﬁbril) andperiodicity (bead-to-beaddis-
tance) [37]. A customroutinewaswritten in ImageSXM[38] to allow
semi-automated analysis of the AFM images to determine microﬁ-
bril length and periodicity. Microﬁbril length (n = 100) was quanti-
ﬁed as the number of repeats of the characteristic beaded structure.
With this custom ImageSXM routine, the AFM image is loaded
with ‘‘line-by-line compensation’’ to reduce the scan line noise
inherent in all scanning probe microscopy images. Any artifacts
in the image, for example, due to impurities on the sample surface,
are identiﬁed and the compensation is automatically applied again
to improve the discrimination between the microﬁbril beads and
the background. The image is then inverted (to display dark beads
on a light background) to enhance contrast. For each microﬁbril
identiﬁed in the image, the x – y position of each bead is recorded
to subsequently calculate microﬁbril periodicity. The number of
repeats for each microﬁbril is also recorded to calculate the length
of the microﬁbril.
2.4.3. Molecular combing of isolated ﬁbrillin microﬁbrils
The extensibility of isolated ﬁbrillin microﬁbrils can be charac-
terized using molecular combing [26], a technique which employs
a receding meniscus to align and straighten partially adsorbed
molecules [39]. We subjected microﬁbrils extracted from control
and diabetic aortas to molecular combing and subsequently quan-
tiﬁed their ability to resist an applied surface tension tensile force
of 4000 pN by measuring microﬁbril periodicity in AFM height
images [26]. Following application of this force, the relative
extensibility of the microﬁbrils can be characterized by comparing
Fig. 1. (a) SAM images of rat aorta (200  200 lm) prior to any ﬁxation or staining. Lamellar (L) and inter-lamellar (IL) regions of the aorta are highlighted. (b) The same
section as shown in (a) following polarized light microscopy of Picro-sirius red (PSR) stained and hence birefringent collagen ﬁbres. Scale bar 50 lm.
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the number of extended repeats in control and experimental
populations.
2.4.4. In vitro glycation of ﬁbrillin microﬁbrils
To determine if changes in microﬁbril structure and extensibil-
ity may be induced by glucose-derived cross-linking (glycation),
isolated ﬁbrillin microﬁbrils (derived from the descending aorta
of a healthy adult Wistar rat and suspended in column buffer:
400 mM NaCl, 50 mM, Tris–HCl, pH 7.4) were exposed to glucose
concentrations of 0, 5 or 100 mmol l–1 for 15 days at 37 C (incuba-
tion times and glucose concentrations were adapted from Ref.
[40]). The microﬁbril suspension was divided into three 1 ml
aliquots. The ﬁrst (control) aliquot was supplemented with a bac-
teriostatic agent (0.01% sodium azide) and incubated for 12 h at
4 C. The second and third aliquots were dialysed (through Visking
tubing: MW cut-off 14 kDa) against 1 l of column buffer supple-
mented with 0.01% sodium azide, and either 5 mmol l–1 or
100 mmol l–1 glucose, respectively, for 18 h (with one buffer
change) at 4 C. Subsequently, all aliquots were incubated at
37 C for 15 days, following which the microﬁbril structure was
characterized from AFM height images of both combed and non-
combed AFM samples as previously described (n = 500 periodicity
measurements per group).
2.5. Statistical analysis
Data are expressed as means ± SEM. Standard deviations (SDs)
are also reported and indicated as such when reported. The
Mann–Whitney U test was used to compare medial wall thickness,
acoustic wave speed, collagen content, elastin content, microﬁbril
periodicity and length in the control and diabetic groups. The
Kolmogorov–Smirnov test was used to compare the distribution
of microﬁbril periodicities. The Kruskal–Wallis ANOVA test was
used for statistical analysis of microﬁbrillar structural parameters
following in vitro exposure to glucose. Where depicted, box and
whisker plots represent the interquartile range, with the ﬁrst and
99th percentile shown with an x symbol. The whiskers represent
the upper inner and lower inner fence values.
3. Results
3.1. Histological analysis
The aortas of both healthy and diabetic rats were composed of
outer adventitial and inner medial layers. In turn the medial layer
comprised 7–8 discrete elastic lamellae in both diabetic and control
animals (Fig. 2a and b). However, the thickness of the medial layer
was signiﬁcantly lower in thediabetic group (81.9 ± 6.6 lm)as com-
pared to the controls (90.7 ± 2.2 lm) (Mann–Whitney U-test,
P < 0.001) (Fig. 2c). Overall, the diabetic medial thickness wasmuch
more variable (Fig. 2b),withmeanvalues ranging from65 to103 lm
compared with 85–97 lm in controls.
Despite these STZ treatment-induced changes in medial layer
thickness, there was no signiﬁcant difference in the abundance of
ﬁbrillar collagen between the diabetic (30.4 ± 1.9%) and control
aortas (31.0 ± 1.6%) (Mann–Whitney U-test, P = 0.054). Similarly
elastin abundance was also unaffected by STZ treatment (control
69.1 ± 2.2%; diabetic 66.1 ± 2.2%) (Mann–Whitney U-test,
P = 0.064). (Fig. 3).
3.2. Acoustic wave speed
Diabetes induced changes in vessel morphology were associ-
ated with localized reductions in acoustic wave speed. The mean
wave speed of the elastic lamellae remained unchanged in diabetic
rat aortas compared with controls (control = 1883 ± 6 m s1; dia-
betic = 1874 ± 7 m s1, Mann–Whitney U-test, P = 0.41), as shown
in Fig. 4a, but was signiﬁcantly reduced (by 34 m s1) in the
inter-lamellar regions (Mann–Whitney U-test, P < 0.01) with the
wave speed frequency distribution being unimodal as compared
to bimodal in the controls (Fig. 4b).
3.3. Protease activity
The structure and mechanical properties of large arteries such
as the aorta are dominated by the ECM proteins, which in turn
are thought to be remodelled in situ primarily by members of a
large family of zinc-dependent endopeptidases: the matrix
metalloproteinases (MMPs) [41]. These MMPs, which are active
in diabetic vessels [12,42,43], also act as gelatinases; hence in this
study we used in situ gelatin zymography to localize and quantify
aortic gelatinase activity in both control and diabetic vessels. Gel-
atinase activity was concentrated in the inter-lamellar regions in
both diabetic and control vessels but was signiﬁcantly higher in
STZ treated animals (P < 0.0001) (Fig. 5a–d). As shown in Fig. 5e,
the mean pixel intensity was higher in the diabetic (51.6 absor-
bance units: A.U.) compared with the controls (40.6 A.U.) The key
Fig. 2. Reduced medial thickness in the diabetic aorta. Typical Millers elastic
stained cryosections, used to determine medial thickness, are shown for (a) control
and (b) diabetic aortas. The variation in medial thickness across the two groups is
evident from the box chart (c). Scale bar: 25 lm.
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gelatinases such as MMPs 2, 3, 9, 12 and 13, which are present in
the diabetic aorta, are also known to degrade ﬁbrillin microﬁbrils
[44]; thus we next determined if these important elastic ﬁbre com-
ponents have the potential to act as structural biomarkers of accu-
mulated damage in diabetic tissues.
3.4. Fibrillin microﬁbril ultrastructure and extensibility
Mammalian aortas are abundant sources of ﬁbrillin microﬁbrils.
These assemblies form extensive chains with typical repeat dis-
tances (periodicities) of 56 nm [26,45]. Although abundant ﬁbrillin
microﬁbrils were isolated from all arterial tissue samples regard-
less of disease state (Fig. 6a), microﬁbrils extracted from diabetic
tissue were signiﬁcantly shorter (Fig. 6b). The control mean length
was 21 ± 1 beads as compared to 18 ± 2 beads in the diabetic group
(Mann–Whitney U test, P < 0.001). Microﬁbril length was also less
variable in the control group as compared to the diabetic group, as
was evident by the lower standard deviation (control SD 13 beads;
diabetic SD 19 beads). Furthermore, the diabetic group exhibited
an altered periodicity distribution compared to assemblies derived
from control tissue (Fig. 6c–e). Overall, mean microﬁbril periodic-
ity was higher in the diabetic group (control mean = 57.2 ± 0.6 nm;
diabetic mean = 59.2 ± 0.8 nm). The two distributions were signiﬁ-
cantly different (Kolmogorov–Smirnoz test, P < 0.01). In the dia-
betic group, 27.1% of microﬁbrils were extended above 65 nm as
compared to 16.1% in the controls. Speciﬁcally, the periodicity dis-
tribution of control microﬁbrils was unimodally distributed with a
peak centred at 56 nm whereas microﬁbrils extracted from dia-
betic tissue were distributed into two populations with resting
periodicities 51 and 73 nm. A Lorentzian ﬁt of the periodicity his-
togram data conﬁrmed that in the control group the distribution
is centred at 56 nm (R2 = 0.95 nm). In contrast, the mean microﬁ-
bril periodicity in the diabetic group was found to follow a
bi-modal distribution centred at 51 and 73 nm, R2 = 0.89 nm).
The ﬁtted data are shown in Fig. 6e.
In addition to their biochemical role in mediating tissue homeo-
stasis, ﬁbrillin microﬁbrils are required to perform mechanical
roles both on their own (in the eye where they suspend the lens
and in skin where they intercalate into the dermal–epidermal
junction) and potentially in combination with elastin, where they
reinforce the elastic ﬁbre [26,46,47]. Hence in this study, we
employed molecular combing to apply a capillary tensile force to
partially adsorbed microﬁbrils (Fig. 7a). Following application of
this force signiﬁcantly more repeats were extended beyond
60 nm in the diabetic as compared with the control populations.
Extension beyond 60 nm was observed in only 37% of microﬁbril
repeats within the control population, compared with 50% of the
repeats measured in the diabetic population (Kolmogorov–Smir-
nov test, P < 0.05) (Fig. 7b).
3.5. Fibrillin microﬁbril ultrastructure and extensibility following
in vitro glycation
ECM components including ﬁbrillar collagens and elastin may
accumulate glucose-derived cross-links with both increasing age
and diabetes, which may, in turn, affect the molecular and hence
macromechanical properties of tissues [48]. As isolated ﬁbrillin
monomers are susceptible to glycation [49], in this study we deter-
mined whether direct exposure to glucose could recapitulate
in vitro the structural and mechanical effects of diabetes on ﬁbrillin
microﬁbril structure and extensibility which we observed in vivo.
Fig. 3. (a) Collagen content: there were 56 and 55 measurements in the control and
diabetic group, respectively. (b) Elastin content: there were 57 and 72 measure-
ments in the control and diabetic group, respectively.
Fig. 4. Acoustic wave speed. (a) Acoustic wave speed of elastic lamellae regions. (b)
Acoustic wave speed of inter-lamellar regions. Note there is a loss of a distinct peak
(at an acoustic wave speed of 1850–1900 m s1) in the diabetic group (n = 80
measurements per group).
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Isolated microﬁbrils were exposed to 5 mmol l–1 and 100 mmol l–1
glucose concentrations at physiological temperatures in vitro.
However, despite the prolonged exposure time (more than
2 weeks), we observed no correlation between glucose
concentration and microﬁbril periodicity, as shown in Fig. 8a
(control [no glucose] mean = 64.0 ± 1.2 nm; 5 mmol l–1 mean = 64.3
nm ± 1.2 nm; 100 mmol l–1 mean = 63.0 ± 0.9 nm), Kruskall–Wallis
ANOVA P = 0.45. There was also no signiﬁcant difference in period-
icity between control microﬁbrils and microﬁbrils exposed to
100 mmol l–1 glucose (ANOVA, P = 0.52). Furthermore, there was
no correlation between glucose concentration and microﬁbril
periodicity following molecular combing as shown in Fig. 8b
(control [no glucose] mean = 63.6 ± 1.1 nm; 5 mmol l–1 mean =
65.1 ± 1.8 nm; 100 mmol l–1 mean = 63.9 ± 1.0 nm; Kruskal–Wallis
ANOVA, P = 0.63).
4. Discussion
In this study, we have utilized one of the most widely used ani-
mal models of human disease, where diabetes is induced by selec-
tive destruction of the insulin-producing B-cells of the pancreas
with a single, rapid injection of STZ [50]. The chronic STZ diabetic
rat has been found to mimic many of the chronic complications
that are observed in the diabetic human, and has further potential
as a model to test new therapeutic approaches for the alleviation of
chronic diabetic complications in humans [50]. Due to its associa-
tion with relatively acute insulin deﬁciency, the model can also be
useful to compare with pathophysiological changes in newly diag-
nosed Type 1 diabetic patients, i.e. before insulin treatment has
begun [51]. Tomlinson et al. [51] have provided a detailed review
of functional changes in the cardiovascular system in the STZ
model, with reference to pathological chronic diabetes in humans.
The data we report in this study support the hypothesis that
experimentally induced diabetes may cause protease-mediated
morphological and micro-mechanical remodelling of the ECM.
Our ﬁndings also suggest that STZ-treatment primarily affects ves-
sel architecture (at multiple lengths scales) rather than molecular
composition. Collagen content has previously been reported to
increase [6,8], decrease [10] and remain unchanged [11] in the dia-
betic aorta. The data presented here support the observations of
Salum et al. [11] that diabetes induces loss of medial layer organi-
zation and thickness. We further show that the structure and stiff-
ness of the ﬁbrillin microﬁbril are compromised in diabetic vessels.
These structural changes, in turn, have functional implications for
the micro-mechanical stiffness of the vessel.
4.1. Acoustic wave speed
Gross changes in rat vessel compliance may only become evi-
dent in the latter stages of hypertension and at supra-physiological
arterial pressures [11]. In common with the pulse wave velocity
(PWV) measurements of vessel stiffness as employed by Salum
et al. [11], our assessment of acoustic wave speed in the medial
layer failed to distinguish between the healthy and diabetic groups.
Hence the relative insensitivity of gross mechanical measurement
methods may explain the current lack of consensus with regard to
mechanical consequences of diabetes in large arteries [8,52].
However, using SAM to resolve the individual mechanical contri-
butions of discrete vessel sub-structures [18], we identiﬁed
signiﬁcant changes in acoustic wave speed that were localized to
Fig. 5. Gelatinase activity. (a)–(d) Florescent micrographs of control (a) and (b), and diabetic (c) and (d) aorta cryosections. Green ﬂuorescence (FITC) indicates areas of
gelatinase activity whilst blue ﬂuorescence (DAPI) marks DNA in cell nuclei. (e) Box and whisker plot showing difference in gelatinase activity. (f) This activity is localized to
the interlamellar regions which contain vascular smooth muscle cells (as visualized by DAPI). Scales bars 50 lm (a–d) and 20 lm (f).
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the inter-lamellar regions of the medial layer. Therefore this tech-
nique is able to identify both localized increases in ageing sheep
aorta [18] and CT-1 exposed rats [20]), as well as decreases
(STZ-treated rats – this study) in the acoustic wave speed of medial
inter-lamellar regions.
4.2. Protease activity
The adverse inﬂuence of diabetes on both the architecture of
the elastic ﬁbre system [53] and the molecular structure and
mechanical properties of elastin is well established [54] and there
is substantial evidence that increased ECM-protease activity may
play a major role in mediating structural and hence mechanical
remodelling in the diabetic aorta [12,48]. Given that all three
implicated MMPs (2, 9 and 12), in common with most MMPs,
not only act as gelatinases [42] but also degrade ﬁbrillin microﬁ-
brils, we used in situ gelatin zymography both to locate protease
activity to the inter-lamellar regions of the medial layer and to
demonstrate that this activity was increased in diabetic vessels.
These data suggest that the ultrastructural and mechanical remod-
elling which we observe in the isolated microﬁbrils and the vessel
wall may, in part, be driven by activated MMPs. In future work, it
would be help to further identify protease classes using in situ
elastin zymography.
4.3. Fibrillin microﬁbrils
As ﬁbrillin microﬁbrils, in common with other ECM structural
components, are thought to have a tissue half-life of many years
[20,55], we tested the hypothesis that they may accumulate mac-
romolecular damage in diabetic vessels and hence act as structural
biomarkers of disease progression. In normal, healthy connective
tissues ﬁbrillin microﬁbrils have a characteristic periodicity of
56 nm [46]. However, it has been reported that alterations in
microﬁbril periodicity can be induced by heritable mutations in
the ﬁbrillion-1 gene (FBN-1) [56], by modiﬁcation of the in vitro
environment such as via calcium chelation [57,58], reduced salt
concentration [59] and also by adsorption to high surface energy
substrates [38]. Within the whole organism such genetic modiﬁca-
tions can adversely affect microﬁbril function; speciﬁcally, FBN-1
point mutations. Mutations in the ﬁbrillin-1 gene FBN-1 may cause
aberrant ﬁbrillin microﬁbril assembly and hence the profound aor-
tic pathologies which characterize Marfan syndrome [50]. Here we
demonstrate that microﬁbril structure and extensibility [26] may
also be compromised in a diseased tissue. These observations
Fig. 6. Fibrillin microﬁbril morphology. (a) Abundant ﬁbrillin microﬁbrils were isolated from control and diabetic aorta and imaged with AFM. (b) Fibrillin microﬁbril length
(n = 100 length measurements per group). (c) Mean microﬁbril periodicity. Each bar represents an individual animal. 500 individual periodicity measurements were made for
each animal. (d) Histogram showing a unimodal distribution in the controls as compared to bi-modal periodicity distribution in the diabetic group. (e) Lorentzian ﬁt of the
periodicity histogram data conﬁrming that in the control group the distribution is centred at 56 nm (Lorentzian ﬁt, R2 = 0.95 nm) whereas in the diabetic group it follows a bi-
modal distribution centred at 51 and 73 nm, Lorentzian ﬁt, R2 = 0.89 nm). Note there are two ﬁtted peaks for the diabetic group (in red).
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support our hypothesis for the potential utility of ﬁbrillin microﬁ-
brils as structural biomarkers of tissue remodelling and also sug-
gest that protease mediated remodelling of microﬁbril structure
may promote further remodelling of the tissue because of aberrant
downstream TGF-b sequestration by functionally incompetent
microﬁbrils [60]. Finally, our data indicate that glycation events
are unlikely to mediate the modiﬁcation of microﬁbrils in vivo.
Although Atanasova et al. [41] demonstrated that human aortic
ﬁbrillin-1 monomers were susceptible to non-enzymatic glycation,
in its assembled form many regions of the monomer are shielded
from enzymatic action [61] and hence potentially from reaction
with glucose. The importance of a quaternary structure in mediat-
ing non-enzymatic glycation events has previously been suggested
by Slatter et al. [62] for collagen ﬁbrils.
In summary, our study demonstrates that in diabetes there is a
profound change in the inter-lamellar regions of the medial layer
of the aorta coupled with an altered morphology and reduced
extensibility of ﬁbrillin microﬁbrils. It therefore seems likely that
there is an early loss of arterial integrity in diabetes, as suggested
by Salum et al. [11], which is not detectable with conventional
in vivo or in vitro mechanical testing methods. Further studies will
be required to identify the biochemical nature and precise molec-
ular pathology of these structural and micro-mechanical remodel-
ling events.
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Appendix A. Figures with essential color discrimination
Certain ﬁgures in this article, particularly Figs. 1, 2, 5–7 are dif-
ﬁcult to interpret in black and white. The full color images can be
found in the on-line version, at http://dx.doi.org/10.1016/
j.actbio.2014.07.001.
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